Point-of-care diagnostics will rely upon the development of low-cost, noncomplex, and easily integrated systems in order to examine biological samples such as blood and urine obtained from the patient.The development of metal ion sensors is a subject of significant relevance for physiological samples.The level of Metal Skewers different blood elect
Case Report on Secondary Peritonitis Caused by Jejunum Perforation
The small intestine is third in frequency intraperitoneal organ injured after blunt trauma of Pillow Protectors abdomen.Peritonitis caused by isolated jejunum perforation is very rare.As most of these cases are accompanied with injuries with other structures in the abdomen, hence it is not suspected.Therefore failure in diagnosis and delay in treat
Research Trends of the Internet of Things in Relation to Business Model Innovation: Results from Co-Word and Content Analyses
In the era of the Internet of Things, innovative business model initiatives continue to deepen, and the trend of search domains continues to expand.This paper aims to Maryland scientifically analyze research trends of the Internet of Things in relation to Business Model Innovation through bibliometric studies.The data were collected using the Clari
Primary Cardiac Tumor Identified as the Cause of Seizure
A Source Naturals 65-year-old woman presented to the emergency department after a seizure.An unexplained bradycardia and heart murmur were detected and an emergency bedside echocardiography was performed.This revealed a mass in the left atrium.The provisional diagnosis of left atrial tumor was later confirmed by formal echocardiography and ultimate
Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
The majority of gastrointestinal stromal tumors (GIST) harbor an activating mutation in either the KIT or PDGFRA receptor tyrosine kinases.Approval of imatinib, Firearms Accessories a KIT/PDGFRA tyrosine kinase inhibitor (TKI), meaningfully improved the treatment of advanced GIST.Other TKIs subsequently gained approval: sunitinib as a second-line t